Challenges in antigenic characterization of circulating influenza A(H3N2) viruses during the 2011-2012 influenza season: an ongoing problem?

scientific article

Challenges in antigenic characterization of circulating influenza A(H3N2) viruses during the 2011-2012 influenza season: an ongoing problem? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JCM.03236-14
P8608Fatcat IDrelease_2gapba7l6faeldym27sn6ieroi
P932PMC publication ID4400766
P698PubMed publication ID25694524

P50authorAdam MeijerQ89899877
P2093author name stringAntonios Kalliaropoulos
Mary Emmanouil
Nikolaos Malisiovas
Athanasios Kossyvakis
Andreas F Mentis
Georgia Gioula
Maria Exindari
Afroditi Moutousi
Vasiliki Pogka
Elina Horefti
Georgia Spala
Aggeliki Melidou
P2860cites workThe neighbor-joining method: a new method for reconstructing phylogenetic treesQ25939010
Confidence Limits on Phylogenies: an Approach using the BootstrapQ26778379
A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequencesQ27860580
MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony MethodsQ27860929
Predicting the evolution of human influenza A.Q30011145
Influenza and the work of the World Health Organization.Q30331151
Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.Q30360290
Influenza A viruses: new research developmentsQ30404670
Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza virusesQ30419865
Genetic drift influenza A(H3N2) virus hemagglutinin (HA) variants originated during the last pandemic turn out to be predominant in the 2011-2012 season in Northern ItalyQ30423957
Using sequence data to infer the antigenicity of influenza virusQ30652766
Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?Q33990541
Influenza hemagglutinin and neuraminidase membrane glycoproteinsQ34121109
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010Q34129986
Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolutionQ35748703
A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibodyQ36255699
Structural basis of immune recognition of influenza virus hemagglutininQ37925554
Substitutions near the receptor binding site determine major antigenic change during influenza virus evolutionQ42253862
Strengthening the influenza vaccine virus selection and development process: outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conférences (CICG) Geneva, Switzerland, 7 tQ43436136
Evidence for host-cell selection of influenza virus antigenic variantsQ45804806
Molecular and phylogenetic analysis and vaccine strain match of human influenza A(H3N2) viruses isolated in Northern Greece between 2004 and 2008.Q46275838
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variationQ59062494
Vaccines against influenza WHO position paper – November 2012Q85607288
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)1493-1499
P577publication date2015-02-18
P1433published inJournal of Clinical MicrobiologyQ4041880
P1476titleChallenges in antigenic characterization of circulating influenza A(H3N2) viruses during the 2011-2012 influenza season: an ongoing problem?
P478volume53

Reverse relations

cites work (P2860)
Q30395244Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment
Q94662614Effectiveness of quadrivalent influenza vaccine in pregnant women and infants, 2018-2019
Q31137989Improving influenza virological surveillance in Europe: strain-based reporting of antigenic and genetic characterisation data, 11 European countries, influenza season 2013/14.
Q89600520Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019
Q92557510Partnering for enhanced digital surveillance of influenza-like disease and the effect of antivirals and vaccines (PEDSIDEA)

Search more.